Literature DB >> 21199428

Australian & New Zealand Faculty of Radiation Oncology Genito-Urinary Group: 2010 consensus guidelines for definitive external beam radiotherapy for prostate carcinoma.

A J Hayden1, J M Martin, A B Kneebone, M Lehman, K L Wiltshire, M Skala, D Christie, P Vial, R McDowall, K-H Tai.   

Abstract

External beam radiotherapy for prostate cancer has undergone substantial technological and clinical advances in the recent years. The Australian & New Zealand Faculty of Radiation Oncology Genito-Urinary Group undertook a process to develop consensus clinical practice guidelines for external beam radiotherapy for prostate carcinoma delivered with curative intent, aiming to provide guidance for clinicians on the appropriate integration of clinical evidence and newer technologies. Draft guidelines were presented and discussed at a consensus workshop in May 2009 attended by radiation oncologists, radiation therapists and medical physicists. Amended guidelines were distributed to radiation oncologists in Australia, New Zealand and Singapore for comment, and modifications were incorporated where appropriate. Evidence based recommendations for risk stratification, the role of image-guided and intensity-modulated radiation therapy, prescribed dose, simulation and treatment planning, the role and duration of neo-adjuvant/adjuvant androgen deprivation therapy and outcome reporting are presented. Central to the guidelines is the recommendation that image-guided radiation therapy should be used when definitive external beam radiotherapy for prostate cancer is prescribed. The consensus guidelines provide a co-operatively developed, evidence-based framework for contemporary treatment of prostate cancer with external beam radiotherapy.
© 2010 The Authors. Journal of Medical Imaging and Radiation Oncology © 2010 The Royal Australian and New Zealand College of Radiologists.

Entities:  

Mesh:

Year:  2010        PMID: 21199428     DOI: 10.1111/j.1754-9485.2010.02214.x

Source DB:  PubMed          Journal:  J Med Imaging Radiat Oncol        ISSN: 1754-9477            Impact factor:   1.735


  9 in total

1.  Definitive 3D-CRT for clinically localized prostate cancer: modifications of the clinical target volume following a prostate MRI and the clinical benefits.

Authors:  Shinsaku Yamaguchi; Takayuki Ohguri; Masami Fujii; Katsuya Yahara; Yoshiko Hayashida; Naohiro Fujimoto; Yukunori Korogi
Journal:  Springerplus       Date:  2015-07-15

2.  Obesity does not influence prostate intrafractional motion.

Authors:  Amy Brown; Alex Tan; Scott Cooper; Andrew Fielding
Journal:  J Med Radiat Sci       Date:  2018-01-23

3.  PROstate Multicentre External beam radioTHErapy Using a Stereotactic boost: the PROMETHEUS study protocol.

Authors:  Matthew Richardson; Mark Sidhom; Sarah Gallagher; Mel Grand; David Pryor; Joseph Bucci; Lee Wilton; Sankar Arumugam; Sarah Keats; Jarad M Martin
Journal:  BMC Cancer       Date:  2018-05-24       Impact factor: 4.430

4.  Seminal vesicle interfraction displacement and margins in image guided radiotherapy for prostate cancer.

Authors:  Daisy Mak; Suki Gill; Roxby Paul; Alison Stillie; Annette Haworth; Tomas Kron; Jim Cramb; Kellie Knight; Jessica Thomas; Gillian Duchesne; Farshad Foroudi
Journal:  Radiat Oncol       Date:  2012-08-13       Impact factor: 3.481

5.  Comparison of Oncentra® Brachy IPSA and graphical optimisation techniques: a case study of HDR brachytherapy head and neck and prostate plans.

Authors:  Michael G Jameson; Lucy Ohanessian; Vikneswary Batumalai; Virendra Patel; Lois C Holloway
Journal:  J Med Radiat Sci       Date:  2015-05-20

6.  A prospective study of nomogram-based adaptation of prostate radiotherapy target volumes.

Authors:  Raymond Wu; Hannah Woodford; Anne Capp; Perry Hunter; Gary Cowin; Keen-Hun Tai; Paul L Nguyen; Peter Chong; Jarad Martin
Journal:  Radiat Oncol       Date:  2015-11-25       Impact factor: 3.481

7.  Toxicity and Long-Term Outcomes of Dose-Escalated Intensity Modulated Radiation Therapy to 74Gy for Localised Prostate Cancer in a Single Australian Centre.

Authors:  Joseph Sia; Daryl Lim Joon; Angela Viotto; Carmel Mantle; George Quong; Aldo Rolfo; Morikatsu Wada; Nigel Anderson; Maureen Rolfo; Vincent Khoo
Journal:  Cancers (Basel)       Date:  2011-09-01       Impact factor: 6.639

8.  Tumor staging using 3.0 T multiparametric MRI in prostate cancer: impact on treatment decisions for radical radiotherapy.

Authors:  Felipe Couñago; Elia Del Cerro; Ana Aurora Díaz-Gavela; Francisco José Marcos; Manuel Recio; David Sanz-Rosa; Israel Thuissard; Karmele Olaciregui; María Mateo; Laura Cerezo
Journal:  Springerplus       Date:  2015-12-18

9.  Absence of prostate oedema obviates the need for delay between fiducial marker insertion and radiotherapy simulation.

Authors:  Deepti Patel; Alex Tan; Amy Brown; Tilley Pain
Journal:  J Med Radiat Sci       Date:  2020-07-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.